Treatment of hepatocellular carcinoma after transplantation and human rights

Hepatology

Volumn 45, Issue 2, 2007, Pages 263-265

  Crippin, Jeffrey S ^a,b  

^a BARNES JEWISH HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131;

CHEMOEMBOLIZATION; EDITORIAL; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER GRAFT; LIVER TRANSPLANTATION; MEDICAL ETHICS; MEDICAL SOCIETY; MICROMETASTASIS; ORGAN DONOR; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT DISEASE; TUMOR DIAGNOSIS; TUMOR VOLUME; UNITED STATES;

CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CHINA; HUMAN RIGHTS; HUMANS; IODINE RADIOISOTOPES; LIVER NEOPLASMS; LIVER TRANSPLANTATION; NEOPLASM RECURRENCE, LOCAL; PERIODICALS; PRISONERS; TISSUE AND ORGAN PROCUREMENT;

EID: 33847738213     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21545     Document Type: Editorial

References (11)

1. Mazzaferro V, Regalio E, Doci R, Andreola S, Pulvirneti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.
2. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact patient survival. HEPATOLOGY 2001;33:1394-1403.
3. Yao FY, Hirose R, LaBerge JM, Davern TJ, Bass NM, Kerlan RK, et al. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl 2005;11:1505-1514.
4. Perez Saborido B, Meneu JC, Morenao E, Garcia I, Moreno A, Fundora Y, et al. Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma? Am J Surg 2005;190:383-387.
5. Xu J, Shen Z, Chin X, Zhang Q, Bian H, Zhu P, et al. A randomized controlled trial of LICARTIN for prevention of hepatoma recurrence after liver transplantation. HEPATOLOGY 2007;45:269-276.
6. Toole BP. Emmprin (CD147), a cell surface regulator of matrix metalloproteinase production and function. Curr Top Dev Biol 2003;54:371-389.
7. Chen ZN, Shang P, Li Y, Qian AR, Zhu P, Xing JL, inventors; NTD Patent and Trademark Agency, Beijing office, assignee. HAb18G/CD147, its agonist and application. Chinese patent ZL01131735.3, 2001 Sep 28; PCT international patent W002/094875. 2002 May 27.
8. Chen ZN, Xing JL, Zhang SH, inventors; NTD Patent & Trademark Agency, Beijing office, assignee. Anti-human hepatoma monoclonal antibody HAb18 light/heavy chain variable region gene, and use thereof. Chinese patent ZL02114471.0, 2002 March 15; PCT international patent W003/078469. 2003 March 17.
9. 131I) metuximab injection: clinical phase I/II trials. Int J Radiat Oncol Biol Phys 2006;65:435-444.
10. American Society of Transplantation. Statement on Ethics. http://a-s-t.org/about/generalethics.htm; accessed December 26, 2006.
11. The World Medical Association. Policy. http://www.wma.net/e/policy/b3. html; accessed December 30, 2006.